Forbes November 15, 2023
People who are hospitalized, especially in intensive care, are often given a central venous catheter (aka a “central line”) — tubes placed in veins close to the heart to deliver the medications and fluids necessary for their recovery. Because these central lines are often needed for long periods of time (up to a year in some situations), they are difficult to keep sterile and infections through them are common, costly and potentially deadly. The Department of Health and Human Services estimates there are between 84,000 and 204,000 such infections annually, and as many as 25,000 related deaths, costing the healthcare system up to $21 billion a year.
This is where New Jersey-based CorMedix comes in. The company has developed a...
Today's Sponsors
Today's Sponsor